Roswell Park Cancer Institute (RPCI), an NCI-Comprehensive Cancer
Center in Buffalo, N Y, is seeking to expand research in cancer genomics
in order to further develop personalized cancer medicine. RPCI is
committed to developing a world-class cancer genetics and genomics
program that will enhance our understanding of the molecular genetic
mechanisms of cancer; advance and accelerate genomics science and
technology development; and effciently translate laboratory research
in cancer genetics and genomics to improve cancer prevention, early
detection, diagnosis and treatment. To achieve this goal, we invite
applications for the position of Associate or Full Professor of Oncology
in the Department of Cancer Genetics and Genomics. Strong applicants
will be considered for the position of Co-Leader of the Cancer Center
Support Grant (CCSG) Genetics and Genomics Program.
Candidates should have a proven track record of peer-reviewed funding
in the feld of cancer genetics and genomics. The ideal candidate will
have scientifc achievement in research utilizing genomic approaches
to identify and characterize cancer driver genes, expression signatures
and/or genetic components relating to cancer initiation, progression
or treatment response. Candidates should be nationally recognized
for scholarly activity, and demonstrate exceptional leadership and
administrative skills. The successful candidate will be highly
collaborative, eager to develop team science, and involved in translational
research with applications to clinical samples, thereby strengthening
the translational genomics theme of the CCSG Genetics and Genomics
Program. In addition to a distinguished record of scientifc achievement,
the applicant must also be committed to the education and mentorship
of students, post-doctoral fellows and junior faculty.
Candidates must have a Ph. D., M.D. or M.D./Ph. D.; a record of scholarly
activity resulting in publication in high-impact journals; and peer-reviewed, cancer-related funding consistent with an appointment at the
Associate or Full Professor rank. We strongly encourage applications
from physician-scientists, and will arrange complementary secondary
or joint appointments in appropriate clinical departments.
Roswell Park Cancer Institute is America’s frst cancer center founded
in 1898 by Dr. Roswell Park. The mission of the Roswell Park Cancer
Institute is to provide total care to cancer patients, conduct research into
the cause, treatment and prevention of cancer, and to educate the public
and the next generation of researchers who study and treat cancer. Over
its long history, Roswell Park Cancer Institute has made fundamental
contributions to reducing the cancer burden and has successfully
maintained an exemplary leadership role in setting national standards
for cancer care, research and education. Notably, the Institute has been
continuously funded as an NCI Comprehensive Cancer Center for over 40
years, since the inception of this prestigious program. The campus spans
25 acres in downtown Buffalo and consists of 15 buildings with about
1.6 million square feet of space. A dedicated cancer hospital building,
completed in 1998, houses a comprehensive diagnostic and treatment
center. The Institute has recently opened a new outpatient Clinical
Sciences Center and is renovating existing education and research space
to support its future growth and expansion.
Please submit a complete CV (and 5-page NIH Biosketch), a letter of
interest addressing research goals and vision, and contact information
for 3 references to: John J. Krolewski, M.D., Ph.D., John and Santa
Palisano Chair of Cancer Genetics & Genomics, Roswell Park Cancer
Institute, Elm & Carlton Streets, Buffalo, NY 14263, care of Amy
Troutman at firstname.lastname@example.org.
Roswell Park Cancer Institute Is an Affrmative Action/
Equal Opportunity Employer
The EGL Charitable Foundation
Invites you to apply to the
Gruss Lipper Post-Doctoral Fellowship Program
Candidates must hold Israeli Citizenship
Candidates must have completed PhD and/or MD/
PhD degrees in Biomedical Sciences at an accredited
Israeli University/Medical School or be in their fnal
year of study
Candidates must have been awarded a postdoctoral
position in the U.S. at a host research institution
Details regarding the fellowship are available at:
Deadline for Application October 1, 2017
JOB FOCUS: MICROBIOLOGY
Applications Requested for Stand Up To Cancer
(SU2C) Convergence Grants
Goal: develop data- and computation-intensive collaborations that
will advance understanding of the human immune system and cancer
immunotherapy. Collaborations are available and can be arranged with
Microsoft Research researchers and other computer science researchers.
Possible topics to consider:
(a) How can we predict responders and non-responders to checkpoint
or CAR therapies? Can we predict patients that will develop side
effects to these therapies?
(b) How can we relate the peptide sequences of antigens to the nucleic
acid sequences of B and T-cell receptor variable regions? Can we
predict peptide antigens from T-cell receptor sequences?
(c) How do we determine the health of the immune system? How do
we quantify the effects of an aging immune system or exhausted
(d)Can we determine with some confidence the neo-antigens
expressed by tumors that are being recognized by the immune
system in an HLA dependent fashion?
(e) How does the microbiome impact immunotherapy? How does it
communicate with the immune system and the nervous system?
(f) Please feel free to propose additional ideas for projects.
Applications: A letter of intent, listing all members of a team, with a two
to three page description of a project. Collaborative groups of researchers
from diverse institutions are preferred. Curriculum vitae and a recent (fve
year) publication list as well as current funding should be included. Please
submit your applications to www.su2c.org/ConvergenceApplications
by June 30, 2017.